Dutasteride
Back to searchMolecule Structure
Scientific Name
Dutasteride
Description of the Drug
Dutasteride is an antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) in adult males by inhibiting 5-alpha reductase.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01126
http://www.drugbank.ca/drugs/DB01126
Brand Name(s)
Avodart, Dutasteride
Company Owner(s)
Anchen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Bionpharma Inc, Zydus Pharmaceuticals Usa Inc, Vintage Pharmaceuticals Llc, Woodward Pharma Services Llc, Rising Pharma Holdings Inc, Acella Pharmaceuticals Llc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Steroid 5-alpha-reductase | PROTEIN FAMILY | INHIBITOR | CHEMBL2363075 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5903 | |
| Human Metabolome Database | HMDB0015258 | |
| DrugBank | DB01126 | |
| PubChem: Thomson Pharma | 14836607 | 14909902 |
| PubChem | 6918296 | |
| Mcule | MCULE-1602474627 | |
| LINCS | LSM-45861 | |
| Nikkaji | J677.498I | |
| BindingDB | 50340481 | |
| EPA CompTox Dashboard | DTXSID8046452 | |
| DrugCentral | 973 | |
| ChemicalBook | CB3254628 | |
| Guide to Pharmacology | 7457 | |
| rxnorm | AVODART | DUTASTERIDE |
| PubChem: Drugs of the Future | 12014955 | |
| ChEBI | 521033 | |
| ZINC | ZINC000003932831 |
